These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 27083564)
1. Overexpression of Dishevelled-2 contributes to proliferation and migration of human esophageal squamous cell carcinoma. Zhou G; Ye J; Sun L; Zhang Z; Feng J J Mol Histol; 2016 Jun; 47(3):287-95. PubMed ID: 27083564 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of leucine aminopeptidase 3 contributes to malignant development of human esophageal squamous cell carcinoma. Zhang S; Yang X; Shi H; Li M; Xue Q; Ren H; Yao L; Chen X; Zhang J; Wang H J Mol Histol; 2014 Jun; 45(3):283-92. PubMed ID: 24477662 [TBL] [Abstract][Full Text] [Related]
3. RAP1B, a DVL2 binding protein, activates Wnt/beta-catenin signaling in esophageal squamous cell carcinoma. Jia Z; Yang Y; Dengyan Z; Chunyang Z; Donglei L; Kai W; Song Z Gene; 2017 May; 611():15-20. PubMed ID: 28119087 [TBL] [Abstract][Full Text] [Related]
4. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation. Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305 [TBL] [Abstract][Full Text] [Related]
5. Rho/ROCK Pathway Regulates Migration and Invasion of Esophageal Squamous Cell Carcinoma by Regulating Caveolin-1. Liu Z; Yu J; Wu R; Tang S; Cai X; Guo G; Chen S Med Sci Monit; 2017 Dec; 23():6174-6185. PubMed ID: 29288243 [TBL] [Abstract][Full Text] [Related]
6. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma. Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393 [TBL] [Abstract][Full Text] [Related]
7. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma. Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of SPOCK1 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma. Song X; Han P; Liu J; Wang Y; Li D; He J; Gong J; Li M; Tu W; Yan W; Liu M; Huang H; Tian D; Liao J J Mol Histol; 2015 Oct; 46(4-5):347-56. PubMed ID: 26077618 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression. Wang PL; Liu B; Xia Y; Pan CF; Ma T; Chen YJ Mol Med Rep; 2016 Apr; 13(4):3074-82. PubMed ID: 26935396 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of TNFAIP2 suppresses proliferation and metastasis in esophageal squamous cell carcinoma through activation of the Wnt/β-catenin signaling pathway. Xie Y; Wang B Oncol Rep; 2017 May; 37(5):2920-2928. PubMed ID: 28393234 [TBL] [Abstract][Full Text] [Related]
11. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway. Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324 [TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo]. Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma. He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034 [TBL] [Abstract][Full Text] [Related]
14. High Expression of BCCIP β Can Promote Proliferation of Esophageal Squamous Cell Carcinoma. Chen L; Ni S; Li M; Shen C; Lin Z; Ouyang Y; Xia F; Liang L; Jiang W; Ni R; Zhang J Dig Dis Sci; 2017 Feb; 62(2):387-395. PubMed ID: 27995408 [TBL] [Abstract][Full Text] [Related]
15. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway. Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315 [TBL] [Abstract][Full Text] [Related]
16. LncRNA-NEF inhibits proliferation, migration and invasion of esophageal squamous-cell carcinoma cells by inactivating wnt/β-catenin pathway. Zhang J; Hu SL; Qiao CH; Ye JF; Li M; Ma HM; Wang JH; Xin SY; Yuan ZL Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6824-6831. PubMed ID: 30402846 [TBL] [Abstract][Full Text] [Related]
17. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells. Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487 [TBL] [Abstract][Full Text] [Related]
18. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma. Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144 [TBL] [Abstract][Full Text] [Related]
19. MT3-MMP down-regulation promotes tumorigenesis and correlates to poor prognosis in esophageal squamous cell carcinoma. Xue Z; Wu X; Chen X; Luo Q Cancer Med; 2016 Sep; 5(9):2459-68. PubMed ID: 27292876 [TBL] [Abstract][Full Text] [Related]
20. Expression and functional regulation of stemness gene Lgr5 in esophageal squamous cell carcinoma. Lv Z; Yu JJ; Zhang WJ; Xiong L; Wang F; Li LF; Zhou XL; Gao XY; Ding XF; Han L; Cai YF; Ma W; Wang LX Oncotarget; 2017 Apr; 8(16):26492-26504. PubMed ID: 28404917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]